A method is provided for constructing, identifying and using new therapeutic or diagnostic proteins capable of binding to a target cell. Corresponding application runtime data and traffic monitoring data can be selectively output to assist an operator in investigating an anomalous condition. Preferably, a third set screw is supported by the main body and engages the opposite side of the flange from the pair of set screws.